Presentation is loading. Please wait.

Presentation is loading. Please wait.

Rate of phenylalanine oxidation (A) and plasma urea concentrations (B) following ingestion of either 20 or 40 g of whey protein isolate in both the lower.

Published byLesley Gordon Modified over 6 years ago

Similar presentations

Presentation on theme: "Rate of phenylalanine oxidation (A) and plasma urea concentrations (B) following ingestion of either 20 or 40 g of whey protein isolate in both the lower."— Presentation transcript:

1 Rate of phenylalanine oxidation (A) and plasma urea concentrations (B) following ingestion of either 20 or 40 g of whey protein isolate in both the lower lean body mass (LLBM) and higher lean body mass (HLBM) groups. Rate of phenylalanine oxidation (A) and plasma urea concentrations (B) following ingestion of either 20 or 40 g of whey protein isolate in both the lower lean body mass (LLBM) and higher lean body mass (HLBM) groups. Data presented as means with 95% confidence intervals. *Significant difference between doses (P < 0.05). Lindsay S. Macnaughton et al. PHY2 2016;4:e12893 ©2016 by American Physiological Society

Download ppt "Rate of phenylalanine oxidation (A) and plasma urea concentrations (B) following ingestion of either 20 or 40 g of whey protein isolate in both the lower."

Similar presentations

Normal Distribution.

Normal Distribution.
OEE2 Confidence interval: 95% TASEGGFDTNAVATAALLESGNPVVNGK.

OEE2 Confidence interval: 95% TASEGGFDTNAVATAALLESGNPVVNGK.
Schematic of the experimental design.

Schematic of the experimental design.
Fig. 1. Baseline and 3-month infusion protocol

Fig. 1. Baseline and 3-month infusion protocol
Myofibrillar fractional synthesis rate (FSR) presented for each individual participant following ingestion of either 20 or 40 g whey protein isolate in.

Myofibrillar fractional synthesis rate (FSR) presented for each individual participant following ingestion of either 20 or 40 g whey protein isolate in.
VEGF gene expression in HPMVEC and VEGF protein levels in CM

VEGF gene expression in HPMVEC and VEGF protein levels in CM
Copyright © 2011 American Medical Association. All rights reserved.

Copyright © 2011 American Medical Association. All rights reserved.
Effect of anti-proteolysis-inducing factor (PIF) affinity-purified urine from a cachectic patient with pancreactic carcinoma and a healthy control on body.

Effect of anti-proteolysis-inducing factor (PIF) affinity-purified urine from a cachectic patient with pancreactic carcinoma and a healthy control on body.
Plasma leucine (A), phenylalanine (B) and threonine (C) concentrations following ingestion of either 20 or 40 g of whey protein isolate in both the lower.

Plasma leucine (A), phenylalanine (B) and threonine (C) concentrations following ingestion of either 20 or 40 g of whey protein isolate in both the lower.
Figure e-1. Further Meta-analysis of previously reported PD and mtDNA haplogroup associations and the data from this study.   Meta-analysis of published.

Figure e-1. Further Meta-analysis of previously reported PD and mtDNA haplogroup associations and the data from this study.   Meta-analysis of published.
Net metabolic rate of walking at 1. 5 m/s vs

Net metabolic rate of walking at 1. 5 m/s vs
Volume 54, Issue 2, Pages (August 1998)

Volume 54, Issue 2, Pages (August 1998)
Plasma insulin concentrations (A) and insulin secretion rates (B) in response to molar increments of plasma glucose concentration during the graded glucose.

Plasma insulin concentrations (A) and insulin secretion rates (B) in response to molar increments of plasma glucose concentration during the graded glucose.
New Insights into Protein Ingestion

New Insights into Protein Ingestion
Adjusted all-cause mortality risk by dialysate sodium (DNa) and predialysis serum sodium (SNa). Adjusted all-cause mortality risk by dialysate sodium (DNa)

Adjusted all-cause mortality risk by dialysate sodium (DNa) and predialysis serum sodium (SNa). Adjusted all-cause mortality risk by dialysate sodium (DNa)
Comparison of the model incorporating daily dose to that incorporating Cmax. Comparison of the model incorporating daily dose to that incorporating Cmax.

Comparison of the model incorporating daily dose to that incorporating Cmax. Comparison of the model incorporating daily dose to that incorporating Cmax.
Figure 1. Plasma urea concentrations in apolipoprotein E–deficient (apo-E −/−) mice with chronic renal failure (CRF). Figure 1. Plasma urea concentrations.

Figure 1. Plasma urea concentrations in apolipoprotein E–deficient (apo-E −/−) mice with chronic renal failure (CRF). Figure 1. Plasma urea concentrations.
Geometric mean concentration-time profiles of (A) racemic BUP, R-BUP, and S-BUP; (B) racemic OHBUP, RR-OHBUP, and SS-OHBUP; (C) racemic ERY, SR-ERYHBUP,

Geometric mean concentration-time profiles of (A) racemic BUP, R-BUP, and S-BUP; (B) racemic OHBUP, RR-OHBUP, and SS-OHBUP; (C) racemic ERY, SR-ERYHBUP,
Colonopshere-enriched proteins display functional interactions.

Colonopshere-enriched proteins display functional interactions.
Testing the effectiveness of the three-step peptide fractionation method.A, μLC mass chromatograms of SCX fractions for an acidic FFE fraction. Testing.

Testing the effectiveness of the three-step peptide fractionation method.A, μLC mass chromatograms of SCX fractions for an acidic FFE fraction. Testing.

Similar presentations

Ads by Google